{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Clinical+Stability+Assessment&page=2", "query": { "intervention": "Clinical Stability Assessment", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Clinical+Stability+Assessment&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-26T11:18:44.409Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01589302", "title": "PCI-32765 (Ibrutinib) in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-cell Prolymphocytic Leukemia", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Prolymphocytic Leukemia", "Recurrent Small Lymphocytic Lymphoma", "Refractory/Relapsed Chronic Lymphocytic Leukemia" ], "interventions": [ { "name": "ibrutinib", "type": "DRUG" }, { "name": "Correlative laboratory samples", "type": "OTHER" }, { "name": "quality of life assessment", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Kami Maddocks, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 154, "start_date": "2012-05-21", "completion_date": "2026-10-31", "has_results": true, "last_update_posted_date": "2026-04-13", "last_synced_at": "2026-09-26T11:18:44.409Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01589302" }, { "nct_id": "NCT00725894", "title": "Pediatric Locking Nail for the Treatment of Femoral Fractures in Children", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Femur Fracture" ], "interventions": [ { "name": "Pediatric Locking Nail", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Zimmer Biomet", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "8 Years", "maximum_age": "16 Years", "sex": "ALL", "summary": "8 Years to 16 Years" }, "enrollment_count": 33, "start_date": "2007-11", "completion_date": "2013-11", "has_results": false, "last_update_posted_date": "2017-06-21", "last_synced_at": "2026-09-26T11:18:44.409Z", "location_count": 3, "location_summary": "Phoenix, Arizona • Orlando, Florida • Charlotte, North Carolina", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Orlando", "state": "Florida" }, { "city": "Charlotte", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00725894" }, { "nct_id": "NCT05538832", "title": "Remote State Representation in Early Psychosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Psychosis", "Schizophrenia", "Schizo Affective Disorder", "Schizoaffective Disorder", "Schizophreniform Disorders", "Psychotic Disorders", "Psychotic Mood Disorders", "Psychoses, Affective", "Psychosis Nos/Other", "Schizophrenia Spectrum and Other Psychotic Disorders" ], "interventions": [ { "name": "BrainHQ Computerized Cognitive Training - Visual Perception Training Paradigm", "type": "DEVICE" }, { "name": "BrainHQ Computerized Cognitive Training - Visual Cognitive Control Training Paradigm", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "30 Years", "sex": "ALL", "summary": "18 Years to 30 Years" }, "enrollment_count": 152, "start_date": "2022-07-27", "completion_date": "2025-09-30", "has_results": false, "last_update_posted_date": "2025-10-03", "last_synced_at": "2026-09-26T11:18:44.409Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT05538832" }, { "nct_id": "NCT07609069", "title": "Retrospective Kinetic Safety Evaluation of an Intravenous Micellar Excipient Platform", "overall_status": "NOT_YET_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Drug Related Side Effects and Adverse Reactions", "Infusion Reactions" ], "interventions": [ { "name": "PIV-850 (850-picometer Dual-NCE Acidic Matrix)", "type": "DRUG" }, { "name": "Legacy Heterogeneous Payload (Micellar Vehicle)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "PICO IV, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 625, "start_date": "2026-05-21", "completion_date": "2026-07-30", "has_results": false, "last_update_posted_date": "2026-05-29", "last_synced_at": "2026-09-26T11:18:44.409Z", "location_count": 1, "location_summary": "Sacramento, California", "locations": [ { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07609069" }, { "nct_id": "NCT04821830", "title": "Vigor and the LDR in Parkinson Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Parkinson Disease" ], "interventions": [ { "name": "carbidopa/levodopa, as prescribed by treating physician", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Michigan", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "45 Years to 90 Years" }, "enrollment_count": 19, "start_date": "2020-02-12", "completion_date": "2024-04-25", "has_results": true, "last_update_posted_date": "2025-07-18", "last_synced_at": "2026-09-26T11:18:44.409Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT04821830" }, { "nct_id": "NCT01085656", "title": "A Phase I Clinical Trial of OXi4503 for Relapsed and Refractory AML and MDS", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Leukemia, Myelogenous, Acute", "Myelodysplastic Syndromes" ], "interventions": [ { "name": "OXi4503", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 18, "start_date": "2011-02", "completion_date": "2016-01", "has_results": false, "last_update_posted_date": "2017-08-08", "last_synced_at": "2026-09-26T11:18:44.409Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01085656" }, { "nct_id": "NCT03858517", "title": "A Post-Market Clinical Evaluation of the ReUnion TSA System", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Shoulder Arthroplasty" ], "interventions": [ { "name": "ReUnion TSA System", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Stryker Trauma and Extremities", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 51, "start_date": "2019-06-25", "completion_date": "2022-07-08", "has_results": true, "last_update_posted_date": "2025-01-31", "last_synced_at": "2026-09-26T11:18:44.409Z", "location_count": 3, "location_summary": "Peoria, Illinois • Nashville, Michigan • Greenville, South Carolina", "locations": [ { "city": "Peoria", "state": "Illinois" }, { "city": "Nashville", "state": "Michigan" }, { "city": "Greenville", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03858517" }, { "nct_id": "NCT04020185", "title": "Safety and Efficacy Study of IMSA101 in Refractory Malignancies", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Solid Tumor, Adult" ], "interventions": [ { "name": "IMSA101", "type": "DRUG" }, { "name": "Immune checkpoint inhibitor (ICI)", "type": "DRUG" }, { "name": "Immuno-oncology (IO) therapy", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "ImmuneSensor Therapeutics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2019-09-23", "completion_date": "2023-09-15", "has_results": true, "last_update_posted_date": "2024-12-11", "last_synced_at": "2026-09-26T11:18:44.409Z", "location_count": 6, "location_summary": "Scottsdale, Arizona • La Jolla, California • Chicago, Illinois + 3 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Morristown", "state": "New Jersey" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04020185" }, { "nct_id": "NCT03418038", "title": "Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Clonal Cytopenia of Undetermined Significance", "High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements", "Recurrent Diffuse Large B-Cell Lymphoma", "Recurrent Hodgkin Lymphoma", "Recurrent Lymphoma", "Refractory Diffuse Large B-Cell Lymphoma", "Refractory Lymphoma", "Chronic Myelomonocytic Leukemia" ], "interventions": [ { "name": "Ascorbic Acid", "type": "DIETARY_SUPPLEMENT" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Cisplatin", "type": "DRUG" }, { "name": "Cytarabine", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "Gemcitabine Hydrochloride", "type": "DRUG" }, { "name": "Ifosfamide", "type": "DRUG" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Oxaliplatin", "type": "DRUG" }, { "name": "Placebo Administration", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Rituximab", "type": "BIOLOGICAL" }, { "name": "Decitabine", "type": "DRUG" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Core Biopsy", "type": "PROCEDURE" }, { "name": "Bone Marrow Aspiration", "type": "PROCEDURE" }, { "name": "Bone Marrow Biopsy", "type": "PROCEDURE" }, { "name": "Echocardiography", "type": "PROCEDURE" }, { "name": "Positron Emission Tomography", "type": "PROCEDURE" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Central Venous Cannula Insertion", "type": "PROCEDURE" }, { "name": "Portacath Placement", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "DRUG", "OTHER", "BIOLOGICAL", "PROCEDURE" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 80, "start_date": "2018-03-23", "completion_date": "2033-11-02", "has_results": false, "last_update_posted_date": "2026-04-16", "last_synced_at": "2026-09-26T11:18:44.409Z", "location_count": 4, "location_summary": "Mankato, Minnesota • Rochester, Minnesota • Eau Claire, Wisconsin + 1 more", "locations": [ { "city": "Mankato", "state": "Minnesota" }, { "city": "Rochester", "state": "Minnesota" }, { "city": "Eau Claire", "state": "Wisconsin" }, { "city": "La Crosse", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT03418038" }, { "nct_id": "NCT02818751", "title": "Neurofunctional Predictors of Escitalopram Treatment Response in Adolescents With Anxiety", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Anxiety" ], "interventions": [ { "name": "Escitalopram", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of Cincinnati", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "12 Years to 17 Years" }, "enrollment_count": 84, "start_date": "2015-05", "completion_date": "2020-05", "has_results": false, "last_update_posted_date": "2020-11-06", "last_synced_at": "2026-09-26T11:18:44.409Z", "location_count": 1, "location_summary": "Cincinnati, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02818751" } ] }